Promotes translation of CDK–cyclin complex and enhances tumor growth under normoxia condition; sensitizes cancer cells to cisplatin through reduced Nrf2-AKR1C1, the clearance system of reactive oxygen species (ROS). The gene discussed is AKR1C1; the disease is neoplasm.